Sanyo dual-cooling freezer provides sample security

Published: 30-Jun-2011
Manufacturing Research & Development

The upright 728l model is ideal for valuable research or clinical samples

Sanyo has expanded its range of dual-cooling -86°C freezers with the launch of the extra-large capacity MDF-U700VX, an upright 728 litre model which provides maximum sample security for valuable research or clinical samples.

With two independent refrigeration systems the dual-cooling freezers maintain a reliable and uniform -86°C ultralow temperature environment. Should one cooling system suffer an unexpected failure, the other circuit will keep irreplaceable samples safely around -70°C until service can be arranged. This freezer design not only protects precious samples but also prevents the inconvenience and expense of out-of-hours call-outs in the event of a failure of one of the refrigeration systems.

The MDF-U700VX has an extra-large capacity of 728 litres without taking up extra space, thanks to its VIP Plus high efficiency vacuum insulation. In addition to reducing energy use, VIP Plus provides typically 24% more storage capacity compared with a conventionally insulated freezer with the same footprint.

This latest dual-cooling unit offers Sanyo’s industry-first intelligent ECO Mode, optimising compressor operation to match the freezer’s running conditions and minimise energy use. Efficient long-term operation of the freezer is facilitated by the filter-less condenser design, which eliminates the need for routine filter cleaning.

The central door-mounted LCD display panel provides intuitive programming of set points and clear confirmation of freezer status. An on-board data logging function allows the operator to easily check recent freezer performance. Other user-friendly design features include comprehensive alarms, a vacuum release port for smooth door opening, and quiet operation.

The MDF-U700VX is certified as a Class IIa Medical Device (93/42/EEC and 2007/47/EC).

See more

You may also like

Manufacturing

MIR-S100C offers secure operation for cell culture

Read more
For use in high humidity conditions

Trending Articles

  1. AFYREN obtains FSSC 22000 certification for industrial site The AFYREN NEOXY plant is now certified for the production and processing of biobased monocarboxylic acids and their derivatives for the food and feed industries, a guarantee of trust and performance for customers
  2. Top 10 tips for optimal rotary evaporation with Vacuubrand Labtex shares: "In the UK, we supply a comprehensive range of high-quality laboratory and instrumentation vacuum pumps from our trusted partners at Vacuubrand - world leaders in vacuum technology!"
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Landmark NHS‑Galleri trial cuts Stage IV cancers and boosts early detection across England NHS‑Galleri trial shows multi‑cancer blood test sharply reduces late‑stage diagnoses and boosts early detection—possibly signalling a structural change in cancer drug demand, supply chain planning and long-term oncology production strategy
  4. Johnson & Johnson files FDA application for IMAAVY in wAIHA Johnson & Johnson has submitted an sBLA to the US Food and Drug Administration seeking approval of IMAAVY as the first-ever treatment for warm autoimmune haemolytic anaemia, supported by Phase II/III ENERGY trial data showing rapid and durable haemoglobin response
  5. Horizon Europe 2025 grant backs Phase II trial of HER-096 for Parkinson’s disease Herantis Pharma has secured selection for €8m in non-dilutive funding under Horizon Europe to advance a Phase II proof-of-concept study of its subcutaneously delivered Parkinson’s therapy candidate HER-096

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

Manufacturing

MIR-S100C offers secure operation for cell culture

For use in high humidity conditions
Containment

Sanyo installs first cell processing workstation in US

To be used to advance stem cell and cell therapy research at the University of Alabama at Birmingham
Manufacturing

Sanyo incubator offers uniform culturing environment

Includes optional hydrogen peroxide decontamination system
Research & Development

Quotient Sciences extends partnership for ultra-rare disease treatment

This collaboration reinforces Quotient Sciences’ commitment to supporting the manufacture of niche and smaller volume commercial products often overlooked by larger CDMOs
Research & Development

OSE Immunotherapeutics receives positive IDMC review for Phase III ARTEMIA trial

OSE Immunotherapeutics SA has received a second positive recommendation from the Independent Data Monitoring Committee to continue its Phase III ARTEMIA trial of Tedopi in advanced non-small cell lung cancer
Research & Development

Vilnius University scientists reveal new role for CRISPR-Cas9 in bacterial immunity

The researchers report in Molecular Cell that the CRISPR-Cas9 protein plays a previously unknown role in selecting and integrating viral DNA fragments during bacterial immune memory formation
Research & Development

Lilly’s Orforglipron beats oral semaglutide in Phase III ACHIEVE-3 trial with superior weight loss

Head-to-head data published in The Lancet show Eli Lilly's oral GLP-1 candidate orforglipron delivered significantly greater HbA1c reductions and weight loss than oral semaglutide in adults with type 2 diabetes, supporting global regulatory submissions
Subscribe now